Pharmacokinetics and Safety Profile of Digoxin in Infants With Single Ventricle Congenital Heart Disease (DGX01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03877965

Recruitment Status : Enrolling by invitation

First Posted : March 18, 2019

Last Update Posted : March 12, 2021

Sponsor:

Collaborators:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

The Emmes Company, LLC

Information provided by (Responsible Party):

Christoph P Hornik, MD MPH, Duke University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Enrolling by invitation
Estimated Primary Completion Date :	July 1, 2022
Estimated Study Completion Date :	December 1, 2022

To Top